Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
The SURPASS-SEMA trial (NCT05583292) compared tirzepatide directly to semaglutide 1.0 mg in type 2 diabetes, showing tirzepatide 10 mg and 15 mg produced superior HbA1c and weight reductions [11]
Available in multiple vial strengths (600 mg and 1500 mg) to suit diverse research models
JYM L-Carnitine supports utilization by helping transport fatty acids into mitochondria
One article found an increased incidence of aspiration pneumonia among GLP-1 users compared to non-users reporting a hazard ratio of 1.33 (95%CI 1.021.74, p = 0.036) (Australian Diabetes Society, National Association of Clinical Obesity Services, Gastroenterological Society of Australia, and Australian and New Zealand College of Anaesthetists n.d.)
US$ 25.81
US$ 20.82
US$ 21.18
US$ 21.27
US$ 25.62
US$ 29.09
